Evidence map›Paper›PMID 21648071›Full record

ArticleMolecular nutrition & food research2011

The inhibitory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on human colon cancer cells.

Peiju Qiu, Huashi Guan, Ping Dong, Shanshan Guo, Jinkai Zheng, Shiming Li, Yun Chen, Chi-Tang Ho, Min-Hsiung Pan, David Julian McClements and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Peiju QiuDepartment of Food Science, University of Massachusetts, Amherst, MA, USA.
Huashi Guan
Ping Dong
Shanshan Guo
Jinkai Zheng
Shiming Li
Yun Chen
Chi-Tang Ho
Min-Hsiung Pan
David Julian McClements
Hang Xiao
University of Massachusetts Amherst · USOcean University of China · CNRutgers, The State University of New Jersey · USNational Kaohsiung Marine University · TWWashington University in St. Louis · US

Funding

Synergistic chemoprevention of colon cancer by hydroxylated polymethoxyflavonesR21CA139174 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI XIAO, HANG · 2010 to 2011
$373k
NCI NIH HHS CA139174NCI NIH HHS R21 CA139174
6 · The paper itself

Abstract

scopePreviously, we reported that 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (5HHMF), a polymethoxyflavone found in citrus peels, potently inhibited the growth of multiple human colon cancer cells. Herein, we further investigated the anti-cancer mechanisms of 5HHMF in human colon cancer cells. METHODS AND

resultsColony formation assay revealed that 5HHMF dose dependently inhibited colony formation of multiple colon cancer cells. Western blot analysis demonstrated 5HHMF decreased nuclear β-catenin levels and increased the E-cadherin level in a dose-dependent manner. 5HHMF also modified plasma membrane-associated proteins, such as K-Ras, EGFR, and their downstream effectors, such as Akt. Moreover, treatments with 5HHMF inhibited nuclear translocation of NF-κB, which may contribute to its anti-cancer effects. Add-back study showed that the inhibitory effect of 5HHMF was not associated with the production of reactive oxygen species (ROS). In addition, 5HHMF treatment inhibited the capillary tube formation of human umbilical vein endothelial cells (HUVECs) on matrigel, suggesting a potential anti-tumor angiogenesis effect.

conclusionOur results demonstrated that 5HHMF suppressed multiple oncogenic molecular events in colon cancer cells.

Indexed as

Antineoplastic Agents, Phytogenicbeta CateninCadherinsCell Line, TumorColonic NeoplasmsDose-Response Relationship, DrugDrug Screening Assays, AntitumorErbB ReceptorsFlavonesHumansMembrane ProteinsNeovascularization, PathologicNF-kappa BOncogene Protein v-aktReactive Oxygen SpeciesSignal Transduction5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavoneAntineoplastic Agents, Phytogenicbeta CateninCadherinsEGFR protein, humanErbB ReceptorsFlavonesMembrane ProteinsNF-kappa BOncogene Protein v-aktReactive Oxygen Species

Identifiers

PMID21648071
PMCPMC3449327
OpenAlexW1986466971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.